Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H4937

Blue Shield of California

46,499 members

2.5

-1.0 vs 2026Below the 4 star line

Ask about H4937

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

3 · 1.0 pt to 4★

Medication Adherence for Hypertension (RAS antagonists)

3 · 1.0 pt to 4★

Medication Adherence for Cholesterol (Statins)

2 · 1.0 pt to 3★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.11
C17 Plan All-Cause Readmissions3x410%
C10 Osteoporosis Management in Women who had a Fracture230%
C06 Monitoring Physical Activity248%
C16 Improving Bladder Control450%
C15 Reducing the Risk of Falling252%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions259%
C13 Kidney Health Evaluation for Patients with Diabetes364%
C11 Diabetes Care – Eye Exam265%
C19 Transitions of Care366%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.